Kikkoman Corporation (KIKOF)
| Market Cap | 8.40B |
| Revenue (ttm) | 4.90B |
| Net Income (ttm) | 408.54M |
| Shares Out | n/a |
| EPS (ttm) | 0.43 |
| PE Ratio | 20.57 |
| Forward PE | n/a |
| Dividend | 0.17 (1.69%) |
| Ex-Dividend Date | Sep 29, 2025 |
| Volume | 7 |
| Average Volume | 685 |
| Open | 9.90 |
| Previous Close | 8.83 |
| Day's Range | 8.83 - 9.90 |
| 52-Week Range | 8.83 - 12.25 |
| Beta | 0.43 |
| RSI | 27.36 |
| Earnings Date | Aug 5, 2025 |
About Orchard Therapeutics
Kikkoman Corporation, through its subsidiaries, manufactures and sells food products in Japan and internationally. It offers soy sauces, soy sauce soup bases, dipping and marinade sauces, and Del Monte seasonings; soy milk and Del Monte beverages; mirin and wines. The company also manufactures and sells canned fruits, corn products, and tomato ketchup; health foods; and purchases and sells oriental food products, as well as other products. In addition, it produces and sells clinical diagnostic reagents, hygiene inspection agents, and processing... [Read more]
Financial Performance
In 2024, Kikkoman's revenue was 708.98 billion, an increase of 7.29% compared to the previous year's 660.84 billion. Earnings were 61.70 billion, an increase of 9.31%.
Financial StatementsNews
Succession Planning Isn’t Like the TV Show
Sibling rivalry. Lying. Greed. Betrayal. A controlling, narcissistic father and a crumbling family empire with no one to hold it up. Though we could be looking at any number of Shakespearean tragedies...